Targeting MiR-5088-5p Attenuates Radioresistance by Suppressing Slug

Overview

Journal Noncoding RNA Res

Date 2023 Jan 12

PMID 36632615

Authors

Hyun Jeong Seok

Jae Yeon Choi

Joo Mi Yi

In Hwa Bae

Affiliations

Soon will be listed here.

Abstract

Radiotherapy is widely used for cancer treatment, but paradoxically, it has been reported that surviving cancer cells can acquire resistance, leading to recurrence or metastasis. Efforts to reduce radioresistance are required to increase the effectiveness of radiotherapy. miRNAs are advantageous as therapeutic agents because it can simultaneously inhibit the expression of several target mRNAs. Therefore, this study discovered miRNA that regulated radioresistance and elucidated its signaling mechanism. Our previous study confirmed that miR-5088-5p was associated with malignancy and metastasis in breast cancer. As a study to clarify the relationship between radiation and miR-5088-5p identified as onco-miRNA, it was confirmed that radiation induced hypomethylation of the promoter of miR-5088-5p and its expression increased. On the other hand, miR-5088-5p inhibitors were confirmed to reduce radiation-induced epithelial-mesenchymal transition, stemness, and metastasis by reducing Slug. Therefore, this study showed the potential of miR-5088-5p inhibitors as therapeutic agents to suppress radioresistance.

Citing Articles

inhibits gastric cancer progression the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis.

Bai H, Qiu X, Xu C, Guo J World J Gastrointest Oncol. 2024; 16(5):2123-2140.

PMID: 38764835 PMC: 11099451. DOI: 10.4251/wjgo.v16.i5.2123.

The Pivotal Function of SLC16A1 and SLC16A1-AS1 in Cancer Progress: Molecular Pathogenesis and Prognosis.

Zhou Y, Tan F, Wang Z, Zhou G, Yuan C Mini Rev Med Chem. 2024; 24(18):1685-1700.

PMID: 38616756 DOI: 10.2174/0113895575284780240327103039.

DNA Methylation-Based Diagnosis and Treatment of Breast Cancer.

Peng X, Zheng J, Liu T, Zhou Z, Song C, Zhang D Curr Cancer Drug Targets. 2024; 25(1):26-37.

PMID: 38441008 DOI: 10.2174/0115680096278978240204162353.

Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.

Nogueras Perez R, Heredia-Nicolas N, de Lara-Pena L, Andres J, Marchal J, Jimenez G Int J Mol Sci. 2023; 24(21).

PMID: 37958993 PMC: 10647353. DOI: 10.3390/ijms242116010.

References

Zhu H, Fan G . Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis. 2011; 1(2):138-149. PMC: 3207246. View

Yi J, Kang E, Kwon H, Bae J, Kang K, Ahuja N . Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer. Oncotarget. 2017; 8(16):26600-26612. PMC: 5432282. DOI: 10.18632/oncotarget.15722. View

Dracham C, Shankar A, Madan R . Radiation induced secondary malignancies: a review article. Radiat Oncol J. 2018; 36(2):85-94. PMC: 6074073. DOI: 10.3857/roj.2018.00290. View

Herman J, Graff J, Myohanen S, Nelkin B, Baylin S . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996; 93(18):9821-6. PMC: 38513. DOI: 10.1073/pnas.93.18.9821. View

Yamada S, Yanamoto S, Naruse T, Matsushita Y, Takahashi H, Umeda M . Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma. Pathol Oncol Res. 2016; 22(3):625-32. DOI: 10.1007/s12253-016-0049-6. View

Ferrara N . VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002; 2(10):795-803. DOI: 10.1038/nrc909. View

Choi B, Jeong S, Wang G, Park J, Lim D, Kim B . Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells. Int J Mol Med. 2011; 28(4):527-34. DOI: 10.3892/ijmm.2011.726. View

Braunstein S, Nakamura J . Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol. 2013; 3:73. PMC: 3615242. DOI: 10.3389/fonc.2013.00073. View

Antwih D, Gabbara K, Lancaster W, Ruden D, Zielske S . Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics. 2013; 8(8):839-48. PMC: 3883787. DOI: 10.4161/epi.25498. View

10.

Hanna J, Hossain G, Kocerha J . The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019; 10:478. PMC: 6532434. DOI: 10.3389/fgene.2019.00478. View

11.

Seok H, Choi Y, Choi J, Yi J, Kim E, Choi M . Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2. Mol Ther Nucleic Acids. 2021; 25:127-142. PMC: 8365326. DOI: 10.1016/j.omtn.2021.05.004. View

12.

Zhao H, Cheng Y, Dong S, Du J, Gao F, Sun D . Down regulation of miR-143 promotes radiation - Induced thymic lymphoma by targeting B7H1. Toxicol Lett. 2017; 280:116-124. DOI: 10.1016/j.toxlet.2017.07.891. View

13.

Xiao W, Lou N, Ruan H, Bao L, Xiong Z, Yuan C . Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A. Cell Physiol Biochem. 2017; 43(6):2420-2433. DOI: 10.1159/000484395. View

14.

Filipow S, Laczmanski L . Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response. Front Genet. 2019; 10:169. PMC: 6421259. DOI: 10.3389/fgene.2019.00169. View

15.

Manikandan J, Aarthi J, Kumar S, Pushparaj P . Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation. 2008; 2(8):330-4. PMC: 2478731. DOI: 10.6026/97320630002330. View

16.

Kim E, Choi Y, Hwang S, Han Y, Park M, Bae I . IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells. Oncotarget. 2016; 7(52):86836-86856. PMC: 5349958. DOI: 10.18632/oncotarget.13561. View

17.

Brenner D, Curtis R, Hall E, Ron E . Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000; 88(2):398-406. DOI: 10.1002/(sici)1097-0142(20000115)88:2<398::aid-cncr22>3.0.co;2-v. View

18.

Park C, Park M, Kwak H, Lee H, Kim M, Lee S . Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 2006; 66(17):8511-9. DOI: 10.1158/0008-5472.CAN-05-4340. View

19.

Hsu S, Yu B, Wang X, Lu Y, Schmidt C, Lee R . Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine. 2013; 9(8):1169-80. PMC: 3815988. DOI: 10.1016/j.nano.2013.05.007. View

20.

Swarbrick S, Wragg N, Ghosh S, Stolzing A . Systematic Review of miRNA as Biomarkers in Alzheimer's Disease. Mol Neurobiol. 2019; 56(9):6156-6167. PMC: 6682547. DOI: 10.1007/s12035-019-1500-y. View